アブレーション技術市場 – 2029年までの世界予測

Report Overview

The global ablation technology market is projected to reach USD 9.62 billion by 2029 from USD 6.11 billion in 2024, at a CAGR of 9.5% from 2024 to 2029.

世界のアブレーション技術市場は、2024年から2029年まで9.5%のCAGRで成長し、2024年の61億1,000万米ドルから2029年までに96億2,000万米ドルに達すると予測されています。

Increasing risk for targeted diseases, supportive regulatory standards, and strategic partnerships and collaborations have driven demand for ablation technology market.

“The radiofrequency ablation segment of technology segment held the largest share of the market in 2023”

The ablation technology market is segmented based on technology into radiofrequency ablation, laser/light ablation, ultrasound ablation, electrical ablation, cryoablation, microwave ablation, pulsed field ablation and hydrothermal/hydromechanical ablation. Increasing demand for cardiac and tumor ablation procedures, growing awareness for early diagnosis, and technological advancements contributes to the largest share for this segment.

“The consumable segment of product segment held the largest share of the market in 2023”

The ablation technology market is segmented based on product into systems and consumables. Large share of consumables segment is supported by rising adoption of ablation systems in the end user facilities. Consumables need to be replaced for each procedure ensuring the patient safety. Extended application areas such as aesthetics, pain management, recent technological advancements, and strict regulatory policies to ensuring patient safety contribute to the highest share of the segment.

“The cardiovascular disease treatment segment for application segment held the largest share of the market in 2023”.

Based on application, the ablation technology market is segmented by application into cardiovascular disease treatment, cancer treatment, orthopedic treatment, cosmetic/aesthetic treatment, urological treatment, gynecological treatment, pain management, ophthalmological treatment and other applications. Cardiovascular disease treatment segment held largest share of the segment in 2023. Improved success rate of ablation treatment for CVD and emerging technologies in ablation drives the segment growth.

“The Ambulatory surgery centers segment for the end user segment is projected to register a significant CAGR during the forecast period.”

The ablation technology market is segmented by end user into hospitals, surgical centers and ablation centers, ambulatory surgery centers, medical spas and aesthetic clinics & dermatology clinics, and other end users. The hospitals, surgical centers and ablation centers segment accounted for a significant market share in 2023. Improved insurance coverage and an increase in outpatient treatments are two major factors driving the expansion of the ambulatory surgery center segment.

“The market in the Asia pacific region is expected to witness the highest growth during the forecast period.”

Consistent rise in investment for healthcare services and infrastructure, especially in emerging economies, supports the rising installation of ablation systems. Key players in the market are focusing on expanding their presence in emerging countries to cater the increasing demand for ablation procedures. Moreover, the increasing number of hospitals, particularly in APAC region, increases the availability and accessibility of advanced treatment procedures, further driving the demand for ablation systems and consumables.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1–30%, Tier 2–42%, and Tier 3– 28%
• By Designation: Director-level–10%, C-level–14%, and Others–76%
• By Region: North America–40%, Europe–30%, Asia Pacific–22%, Latin America–6%, and the Middle East & Africa–2%

The prominent players in the ablation technology market Johnson & Johnson (US), Medtronic (US), Boston Scientific Corporation (US), Abbott (US), Atricure, Inc. (US), AngioDynamics (US), CONMED corporation (US), Olympus (Japan) among others.

Research Coverage

This report studies the ablation technology market based on technology, product, application, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions.

Reasons to Buy the Report

The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall ablation technology market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:

          Analysis of key drivers (Emerging technologies in the field of ablation, increasing demand for minimally invasive procedures, favorable reimbursement scenario in developed markets, and growing target patient population), restraints (presence of strong alternative therapies, stringent regulatory system), opportunities (growth potential in emerging countries), and challenges (focus on reuse and reprocessing of devices, therapeutic challenges and hazardous effects of ablation) influencing the growth of the ablation technology market

          Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the ablation technology market

          Market Development: Comprehensive information about lucrative markets–the report analyses the ablation technology market across varied regions.

          Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the ablation technology market

         Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players – such as Johnson & Johnson (US), Medtronic (US), Boston Scientific Corporation (US), Abbott (US), Atricure, Inc. (US), AngioDynamics (US), CONMED corporation (US), Olympus (Japan) among others.

Table of Contents

1            INTRODUCTION            28

1.1         STUDY OBJECTIVES      28

1.2         MARKET DEFINITION   28

1.3         INCLUSIONS AND EXCLUSIONS 29

1.4         STUDY SCOPE  30

1.4.1      SEGMENTS CONSIDERED          30

1.4.2      YEARS CONSIDERED     31

1.4.3      CURRENCY CONSIDERED          31

1.5         STAKEHOLDERS            31

1.6         SUMMARY OF CHANGES            32

2            RESEARCH METHODOLOGY     33

2.1         RESEARCH DATA           33

2.1.1      SECONDARY DATA       34

2.1.1.1   Key secondary sources       34

2.1.1.2   Objectives of secondary research     34

2.1.2      PRIMARY DATA 35

2.1.2.1   Key primary sources           35

2.1.2.2   Objectives of primary research         35

2.1.2.3   Key primary insights          36

2.1.2.4   Breakdown of primaries     36

2.2         MARKET SIZE ESTIMATION       37

2.2.1      BOTTOM-UP APPROACH           38

2.2.1.1   Company revenue estimation approach         39

2.2.1.2   Customer-based market estimation  40

2.2.1.3   Growth forecast   41

2.2.1.4   CAGR projections             41

2.3         DATA TRIANGULATION             42

2.4         RESEARCH LIMITATIONS           43

2.5         MARKET SHARE ANALYSIS         43

2.6         STUDY ASSUMPTIONS  43

2.7         GROWTH RATE ASSUMPTIONS 44

2.8         RISK ASSESSMENT         44

3            EXECUTIVE SUMMARY 45

4            PREMIUM INSIGHTS      49

4.1         ABLATION TECHNOLOGY MARKET OVERVIEW 49

4.2         NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,

2024 VS. 2029 (USD MILLION)     50

4.3         ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY END USER,

2024 VS. 2029 (USD MILLION)     51

4.4         EUROPE: ABLATION TECHNOLOGY MARKET, BY APPLICATION,

2024 VS. 2029 (USD MILLION)     52

4.5         GEOGRAPHIC SNAPSHOT OF ABLATION TECHNOLOGY MARKET              53

5            MARKET OVERVIEW     54

5.1         INTRODUCTION            54

5.2         MARKET DYNAMICS     54

5.2.1      DRIVERS            55

5.2.1.1   Emerging ablation technologies       55

5.2.1.2   Increasing demand for minimally invasive procedures  55

5.2.1.3   Growing target patient population   56

5.2.1.3.1 Rapid growth in geriatric population with higher risk of targeted diseases 56

5.2.1.3.2 Increasing incidence of cancer and sports injuries        57

5.2.1.3.3 Rising prevalence of atrial fibrillation and other cardiovascular diseases   57

5.2.1.4   Favorable reimbursement scenario in developed markets           58

5.2.2      RESTRAINTS     59

5.2.2.1   Strong market positioning of alternative therapies       59

5.2.2.2   Stringent regulatory systems            59

5.2.3      OPPORTUNITIES           60

5.2.3.1   Growth potential in emerging economies       60

5.2.4      CHALLENGES   61

5.2.4.1   Focus on reuse and reprocessing of devices    61

5.2.4.2   Therapeutic challenges and hazardous effects of ablation           61

5.3         VALUE CHAIN ANALYSIS            62

5.3.1      RESEARCH & PRODUCT DEVELOPMENT            63

5.3.2      RAW MATERIAL PROCUREMENT AND MANUFACTURING          63

5.3.3      DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES              63

5.4         SUPPLY CHAIN ANALYSIS          63

5.4.1      MANUFACTURERS        64

5.4.1.1   Prominent companies        64

5.4.1.2   Small and medium-sized enterprises 64

5.4.2      END USERS       64

5.5         ECOSYSTEM ANALYSIS 65

5.6         REGULATORY LANDSCAPE       67

5.6.1      REGULATORY ANALYSIS            67

5.6.1.1   North America     67

5.6.1.1.1 US         67

5.6.1.1.2 Canada  69

5.6.1.2   Europe  71

5.6.1.3   Asia Pacific          73

5.6.1.3.1 Japan     73

5.6.1.3.2 China     74

5.6.1.3.3 India      76

5.6.1.4   Latin America      76

5.6.1.4.1 Brazil     76

5.6.2      REGULATORY APPROVALS        77

5.6.3      KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          77

5.6.3.1   North America     77

5.6.3.2   Europe  78

5.6.3.3   Asia Pacific          79

5.6.3.4   Latin America      80

5.6.3.5   Middle East & Africa          80

5.7         REIMBURSEMENT SCENARIO ANALYSIS             81

5.8         INVESTMENT AND FUNDING SCENARIO            82

5.9         PRICING ANALYSIS        84

5.10       TRADE ANALYSIS          87

5.10.1    IMPORT DATA FOR ABLATION PRODUCTS (HS CODE 9018)      87

5.10.2    EXPORT DATA FOR ABLATION PRODUCTS (HS CODE 9018)      88

5.11       PATENT ANALYSIS        88

5.11.1    TOP PATENT OWNERS/APPLICANTS    89

5.11.2    LIST OF MAJOR PATENTS          90

5.12       PORTER’S FIVE FORCES ANALYSIS         91

5.12.1    THREAT OF NEW ENTRANTS    92

5.12.2    THREAT OF SUBSTITUTES         92

5.12.3    BARGAINING POWER OF SUPPLIERS     92

5.12.4    BARGAINING POWER OF BUYERS           92

5.12.5    INTENSITY OF COMPETITIVE RIVALRY 93

5.13       KEY STAKEHOLDERS AND BUYING CRITERIA    93

5.13.1    KEY STAKEHOLDERS IN BUYING PROCESS         93

5.13.2    KEY BUYING CRITERIA 94

5.14       KEY CONFERENCES AND EVENTS, 2024–2025     97

5.15       CASE STUDY ANALYSIS 98

5.15.1    RADIOFREQUENCY ABLATION ANALYSIS CASE STUDY 98

5.15.2    THERMOCOOL CATHETER CASE STUDY            99

5.16       TECHNOLOGY ANALYSIS           99

5.16.1    KEY TECHNOLOGIES    99

5.16.1.1 Thermal ablation technology           99

5.16.1.2 Non-thermal ablation technology    100

5.16.2    COMPLEMENTARY TECHNOLOGIES     100

5.16.2.1 Medical cooling systems     100

5.16.3    ADJACENT TECHNOLOGIES      100

5.16.3.1 Ablation planning software 100

5.17       TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS       101

5.18       UNMET NEEDS 102

5.19       IMPACT OF AI/GEN AI ON ABLATION TECHNOLOGY MARKET  103

5.19.1    KEY USE CASES 104

6            ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY 105

6.1         INTRODUCTION            106

6.2         RADIOFREQUENCY ABLATION 106

6.2.1      LOWER COST AND HIGHER EFFICACY TO PROPEL MARKET GROWTH              106

6.3         LASER/LIGHT ABLATION           108

6.3.1      LOWER RISK OF TISSUE DAMAGE AND BETTER REAL-TIME MONITORING TO AID MARKET GROWTH          108

6.4         ULTRASOUND ABLATION         109

6.4.1      HIGH INCIDENCE OF LIVER TUMORS AND CANCER TO FUEL MARKET GROWTH          109

6.5         ELECTRICAL ABLATION             110

6.5.1      INCREASING NUMBER OF CARDIAC ARRESTS TO BOOST ADOPTION              110

6.6         CRYOABLATION            110

6.6.1      FEWER COMPLICATIONS AND SHORTER PROCEDURAL TIME TO DRIVE MARKET 110

6.7         MICROWAVE ABLATION            111

6.7.1      FASTER ABLATION TIME AND LESSER PROCEDURAL PAIN TO AUGMENT MARKET GROWTH  111

6.8         PULSED-FIELD ABLATION         112

6.8.1      IMPROVED SAFETY, SHORTER PROCEDURAL TIME, AND FEWER COMPLICATIONS TO PROPEL MARKET GROWTH          112

6.9         HYDROTHERMAL/HYDROMECHANICAL ABLATION      113

6.9.1      INCREASED USAGE IN GYNECOLOGICAL DISORDERS AND MENORRHAGIA

TO AID MARKET GROWTH        113

7            ABLATION TECHNOLOGY MARKET, BY PRODUCT         114

7.1         INTRODUCTION            115

7.2         RADIOFREQUENCY ABLATION SYSTEMS            116

7.2.1      TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATION SYSTEMS           117

7.2.1.1   Technological advancements and improved clinical outcomes to propel segment growth   117

7.2.2      FLUID-COOLED RADIOFREQUENCY ABLATION SYSTEMS          117

7.2.2.1   Rising incidence of arrhythmia and growing focus on reducing collateral tissue damage to boost demand   117

7.2.3      ROBOTIC CATHETER MANIPULATION SYSTEMS            118

7.2.3.1   Manual control of catheter movement and remote navigation to fuel segment              118

7.3         LASER/LIGHT ABLATION SYSTEMS       119

7.3.1      EXCIMER LASER ABLATION SYSTEMS   120

7.3.1.1   Low direct tissue interaction, precise ablation zone, and high procedural efficiency to drive adoption 120

7.3.2      COLD LASER ABLATION SYSTEMS         121

7.3.2.1   Cold laser ablator treatment to release endorphins and support pain management              121

7.4         ULTRASOUND ABLATION SYSTEMS      121

7.4.1      ULTRASONIC SURGICAL ABLATION SYSTEMS   123

7.4.1.1   Development of user-friendly surgical ablation systems to drive segment growth              123

7.4.2      HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION SYSTEMS              123

7.4.2.1   Low procedural time and reduced bleeding to support system adoption   123

7.4.3      EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY SYSTEMS         124

7.4.3.1   Growing incidence of obesity and diabetes to drive segment      124

7.4.4      MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND ABLATION SYSTEMS           125

7.4.4.1   Non-pregnancy safe treatment procedure to limit adoption       125

7.5         ELECTRICAL ABLATION SYSTEMS         126

7.5.1      ARGON PLASMA/BEAM COAGULATION SYSTEMS          126

7.5.1.1   Increased focus on treating Barrett’s esophagus without dysplasia to augment segment growth   126

7.5.2      IRREVERSIBLE ELECTROPORATION ABLATION SYSTEMS           127

7.5.2.1   Selective targeting and better control to aid segment growth      127

7.6         CRYOABLATION SYSTEMS         128

7.6.1      TECHNOLOGICAL ADVANCEMENTS AND INTRODUCTION OF NEW CRYOPROBES TO AID ADOPTION          128

7.6.2      EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES   129

7.7         MICROWAVE ABLATION SYSTEMS         129

7.7.1      PRODUCTION OF LARGE ABLATION ZONES WITHOUT HEAT-SINK EFFECT ON SURROUNDING TISSUES TO DRIVE MARKET           129

7.7.2      MICROWAVE THERMOTHERAPY SYSTEMS        129

7.8         HYDROTHERMAL/HYDROMECHANICAL ABLATION SYSTEMS  130

7.8.1      INCREASED NEED FOR MINIMALLY INVASIVE PROCEDURES FOR GYNECOLOGICAL DISORDERS TO SUPPORT MARKET GROWTH            130

7.8.2      ENDOMETRIAL HYDROTHERMAL BALLOON ABLATION DEVICES              130

7.9         CONSUMABLES 131

7.9.1      GROWING PREFERENCE FOR ADVANCED MINIMALLY INVASIVE PROCEDURES TO SPUR MARKET GROWTH       131

8            ABLATION TECHNOLOGY MARKET, BY APPLICATION  132

8.1         INTRODUCTION            133

8.2         CARDIOVASCULAR DISEASE TREATMENT         133

8.2.1      INCREASING TARGET PATIENT POPULATION TO PROPEL MARKET GROWTH          133

8.3         CANCER TREATMENT  134

8.3.1      HIGH PREVALENCE OF CANCER AND NEED FOR ADVANCED TREATMENT PROCEDURES TO AUGMENT MARKET GROWTH  134

8.3.2      LIVER CANCER 135

8.3.3      KIDNEY CANCER            135

8.3.4      PROSTATE CANCER      135

8.3.5      LUNG CANCER 135

8.3.6      BONE METASTASIS       136

8.3.7      BREAST CANCER            136

8.4         ORTHOPEDIC TREATMENT      136

8.4.1      GROWING DISEASE PREVALENCE AND RISING GERIATRIC POPULATION TO SPUR MARKET GROWTH       136

8.5         COSMETIC/AESTHETIC SURGERY          137

8.5.1      INCREASING DEMAND FOR AESTHETIC SURGICAL PROCEDURES TO FUEL MARKET GROWTH            137

8.6         UROLOGICAL TREATMENT       138

8.6.1      HIGH DEMAND FOR MINIMALLY INVASIVE PROCEDURES AMONG PATIENTS TO DRIVE MARKET  138

8.7         GYNECOLOGICAL TREATMENT             139

8.7.1      INCREASING REPRODUCTIVE HEALTH CONCERNS AND DECREASING FERTILITY RATE TO PROPEL MARKET GROWTH            139

8.8         PAIN MANAGEMENT    140

8.8.1      MINIMUM RECOVERY TIME AND LONG-LASTING PAIN RELIEF TO SUPPORT MARKET GROWTH    140

8.9         OPHTHALMOLOGICAL TREATMENT    141

8.9.1      RISING PREVALENCE OF VISION DISORDERS AMONG ALL AGE GROUPS TO AID MARKET GROWTH      141

8.10       OTHER APPLICATIONS 142

9            ABLATION TECHNOLOGY MARKET, BY END USER         143

9.1         INTRODUCTION            144

9.2         HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS     144

9.2.1      HIGH ADOPTION OF ROBOTIC PROCEDURES IN SURGERIES AND IMPROVED HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET          144

9.3         AMBULATORY SURGERY CENTERS        145

9.3.1      NEED FOR COST-EFFECTIVE OUTPATIENT TREATMENTS TO SPUR MARKET GROWTH        145

9.4         MEDICAL SPAS AND AESTHETIC & DERMATOLOGY CLINICS     146

9.4.1      INCREASING PREFERENCE FOR MINIMALLY INVASIVE AND NON-INVASIVE AESTHETIC PROCEDURES TO BOOST MARKET GROWTH      146

9.5         OTHER END USERS        147

10          ABLATION TECHNOLOGY MARKET, BY REGION             148

10.1       INTRODUCTION            149

10.2       NORTH AMERICA          149

10.2.1    MACROECONOMIC OUTLOOK FOR NORTH AMERICA   155

10.2.2    US         156

10.2.2.1 US to dominate North American ablation technology market during forecast period    156

10.2.3    CANADA            157

10.2.3.1 Rising burden of cancer and growing demand for minimally invasive procedures to support market growth   157

10.3       EUROPE             158

10.3.1    MACROECONOMIC OUTLOOK FOR EUROPE     163

10.3.2    GERMANY         165

10.3.2.1 Developed healthcare infrastructure and high incidence of chronic diseases to support market growth       165

10.3.3    FRANCE             166

10.3.3.1 Growing geriatric population and rising prevalence of cancer to aid market growth              166

10.3.4    UK         167

10.3.4.1 Rising target patient population and growing awareness about advanced treatment options to drive market      167

10.3.5    ITALY   168

10.3.5.1 Increasing number of clinical trials and growing focus on advanced research activities to augment market growth 168

10.3.6    SPAIN   168

10.3.6.1 Increasing government research funding and growing focus on effective cancer diagnosis to propel market growth   168

10.3.7    REST OF EUROPE           169

10.4       ASIA PACIFIC    170

10.4.1    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC          177

10.4.2    JAPAN  178

10.4.2.1 Presence of universal healthcare reimbursement system to augment market growth   178

10.4.3    CHINA  179

10.4.3.1 Increased patient pool and favorable government initiatives to fuel market growth              179

10.4.4    INDIA   180

10.4.4.1 Modernization of healthcare infrastructure and increased medical tourism to aid market growth     180

10.4.5    AUSTRALIA       181

10.4.5.1 Increased research investments and favorable government initiatives to spur market growth     181

10.4.6    SOUTH KOREA 182

10.4.6.1 Focus on healthcare R&D and supportive government initiatives to positively impact market growth        182

10.4.7    REST OF ASIA PACIFIC  183

10.5       LATIN AMERICA             184

10.5.1    MACROECONOMIC OUTLOOK FOR LATIN AMERICA     189

10.5.2    BRAZIL 190

10.5.2.1 Increasing government funding and growing burden of chronic diseases to propel market growth     190

10.5.3    MEXICO             191

10.5.3.1 Availability of advanced care initiatives and awareness programs to fuel market growth   191

10.5.4    REST OF LATIN AMERICA          192

10.6       MIDDLE EAST & AFRICA             193

10.6.1    IMPROVED HEALTHCARE INFRASTRUCTURE AND HIGH PUBLIC-PRIVATE INVESTMENTS TO STIMULATE MARKET GROWTH     193

10.6.2    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA     198

11          COMPETITIVE LANDSCAPE       200

11.1       INTRODUCTION            200

11.2       KEY PLAYER STRATEGY/RIGHT TO WIN             200

11.2.1    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ABLATION TECHNOLOGY MARKET             200

11.3       REVENUE ANALYSIS, 2019–2023 203

11.4       MARKET SHARE ANALYSIS, 2023             204

11.5       COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023   205

11.5.1    STARS  205

11.5.2    EMERGING LEADERS    206

11.5.3    PERVASIVE PLAYERS     206

11.5.4    PARTICIPANTS 206

11.5.5    COMPANY FOOTPRINT: KEY PLAYERS, 2023      207

11.5.5.1 Company footprint            207

11.5.5.2 Technology footprint         208

11.5.5.3 Product footprint 209

11.5.5.4 Application footprint         210

11.5.5.5 End-user footprint             211

11.5.5.6 Region footprint  212

11.6       COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023          213

11.6.1    PROGRESSIVE COMPANIES       213

11.6.2    RESPONSIVE COMPANIES          213

11.6.3    DYNAMIC COMPANIES 213

11.6.4    STARTING BLOCKS       213

11.6.5    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023             215

11.7       COMPANY VALUATION AND FINANCIAL METRICS        217

11.7.1    FINANCIAL METRICS    217

11.7.2    COMPANY VALUATION 217

11.8       BRAND/PRODUCT COMPARISON          218

11.9       COMPETITIVE SCENARIO          219

11.9.1    PRODUCT LAUNCHES AND APPROVALS            219

11.9.2    DEALS  220

11.9.3    EXPANSIONS    221

12          COMPANY PROFILES    222

12.1       KEY PLAYERS   222

12.1.1    JOHNSON & JOHNSON  222

12.1.1.1 Business overview 222

12.1.1.2 Products offered  223

12.1.1.3 Recent developments         224

12.1.1.3.1            Product approvals 224

12.1.1.3.2            Deals     225

12.1.1.4 MnM view           225

12.1.1.4.1            Key strengths       225

12.1.1.4.2            Strategic choices  225

12.1.1.4.3            Weaknesses and competitive threats 225

12.1.2    MEDTRONIC     226

12.1.2.1 Business overview 226

12.1.2.2 Products offered  228

12.1.2.3 Recent developments         230

12.1.2.3.1            Product approvals 230

12.1.2.4 MnM view           231

12.1.2.4.1            Key strengths       231

12.1.2.4.2            Strategic choices  231

12.1.2.4.3            Weaknesses and competitive threats 231

12.1.3    BOSTON SCIENTIFIC CORPORATION    232

12.1.3.1 Business overview 232

12.1.3.2 Products offered  233

12.1.3.3 Recent developments         235

12.1.3.3.1            Product approvals 235

12.1.3.3.2            Deals     235

12.1.3.4 MnM view           236

12.1.3.4.1            Key strengths       236

12.1.3.4.2            Strategic choices made       236

12.1.3.4.3            Weaknesses and competitive threats 236

12.1.4    ABBOTT            237

12.1.4.1 Business overview 237

12.1.4.2 Products offered  238

12.1.4.3 Recent developments         239

12.1.4.3.1            Product approvals 239

12.1.4.3.2            Deals     239

12.1.5    ATRICURE, INC.              240

12.1.5.1 Business overview 240

12.1.5.2 Products offered  241

12.1.5.3 Recent developments         242

12.1.5.3.1            Product launches and approvals       242

12.1.6    ANGIODYNAMICS         243

12.1.6.1 Business overview 243

12.1.6.2 Products offered  245

12.1.6.3 Recent developments         246

12.1.6.3.1            Deals     246

12.1.7    CONMED CORPORATION          247

12.1.7.1 Business overview 247

12.1.7.2 Products offered  248

12.1.8    OLYMPUS CORPORATION         249

12.1.8.1 Products offered  250

12.1.8.2 Recent developments         251

12.1.8.2.1            Product launches 251

12.1.8.2.2            Deals     252

12.1.9    VARIAN MEDICAL SYSTEMS, INC.           253

12.1.9.1 Business overview 253

12.1.9.2 Products offered  254

12.1.9.3 Recent developments         255

12.1.9.3.1            Product launches 255

12.1.9.3.2            Deals     255

12.1.10  SMITH+NEPHEW           257

12.1.10.1             Business overview 257

12.1.10.2             Product offered   259

12.1.10.3             Recent developments         260

12.1.10.3.1          Expansions          260

12.1.11  STRYKER           261

12.1.11.1             Business overview 261

12.1.11.2             Products offered  263

12.1.11.3             Recent developments         263

12.1.11.3.1          Product approvals 263

12.1.11.3.2          Expansions          264

12.1.12  CYNOSURE LUTRONIC 265

12.1.12.1             Business overview 265

12.1.12.2             Products offered  265

12.1.12.3             Recent developments         266

12.1.12.3.1          Deals     266

12.1.13  BIOVENTUS      267

12.1.13.1             Business overview 267

12.1.13.2             Products offered  268

12.1.13.2.1          Deals     269

12.1.14  MERIT MEDICAL SYSTEMS        270

12.1.14.1             Business overview 270

12.1.14.2             Products offered  271

12.1.15  CANYON MEDICAL INC.             272

12.1.15.1             Business overview 272

12.1.15.2             Products offered  272

12.2       OTHER PLAYERS           273

12.2.1    ARTHREX, INC. 273

12.2.2    ICECURE MEDICAL       274

12.2.3    MINIMAX MEDICAL HOLDING GROUP  275

12.2.4    CARDIOFOCUS 276

12.2.5    EDAP TMS         277

12.2.6    MERMAID MEDICAL     278

12.2.7    MONTERIS        278

12.2.8    SONABLATE CORP.       279

12.2.9    ECO MEDICAL  280

12.2.10  SURGNOVA       281

13          APPENDIX         282

13.1       DISCUSSION GUIDE      282

13.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             287

13.3       CUSTOMIZATION OPTIONS      289

13.4       RELATED REPORTS       289

13.5       AUTHOR DETAILS         290

LIST OF TABLES

TABLE 1             ABLATION TECHNOLOGY MARKET: INCLUSIONS AND EXCLUSIONS    29

TABLE 2             ABLATION TECHNOLOGY MARKET: STUDY ASSUMPTIONS              43

TABLE 3             ABLATION TECHNOLOGY MARKET: RISK ASSESSMENT 44

TABLE 4             ESTIMATED GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 (IN MILLION)         56

TABLE 5             CPT CODES FOR REIMBURSEMENT OF ABLATION TECHNOLOGIES            58

TABLE 6             ALTERNATIVE THERAPIES/PROCEDURES FOR ABLATION              59

TABLE 7             ABLATION TECHNOLOGY MARKET: ROLE IN ECOSYSTEM              66

TABLE 8             US FDA: MEDICAL DEVICE CLASSIFICATION     67

TABLE 9             US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS              68

TABLE 10           US: CLASSIFICATION OF ABLATION DEVICES    69

TABLE 11           CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS           69

TABLE 12           JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA)    74

TABLE 13           CHINA: CLASSIFICATION OF MEDICAL DEVICES             75

TABLE 14           REGULATORY APPROVALS REQUIRED FOR ABLATION DEVICES, BY COUNTRY 77

TABLE 15           NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         77

TABLE 16           EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         78

TABLE 17           ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         79

TABLE 18           LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         80

TABLE 19           MIDDLE EAST & AFRICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         80

TABLE 20           MEDICAL REIMBURSEMENT CODES FOR CRYOABLATION PROCEDURAL SERVICES IN US (2024)    81

TABLE 21           MEDICAL REIMBURSEMENT CODES FOR ABLATION TECHNOLOGY IN US,

2021–2024          82

TABLE 22           INDICATIVE SELLING PRICE OF ABLATION SYSTEMS, BY REGION,

2021–2023 (USD)             86

TABLE 23           IMPORT DATA FOR ABLATION PRODUCTS (HS CODE 9018), BY COUNTRY,

2019–2023 (USD THOUSAND)     87

TABLE 24           EXPORT DATA FOR ABLATION PRODUCTS (HS CODE 9018), BY COUNTRY,

2019–2023 (USD THOUSAND)     88

TABLE 25           LIST OF MAJOR PATENTS IN ABLATION TECHNOLOGY MARKET,

JANUARY 2022–MARCH 2024      90

TABLE 26           ABLATION TECHNOLOGY MARKET: PORTER’S FIVE FORCES              91

TABLE 27           INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS              94

TABLE 28           INFLUENCE OF KEY END USERS ON BUYING PROCESS  96

TABLE 29           KEY BUYING CRITERIA FOR END USERS              97

TABLE 30           ABLATION TECHNOLOGY MARKET: LIST OF KEY CONFERENCES AND EVENTS, JANUARY 2024–DECEMBER 2025  97

TABLE 31           CASE STUDY 1: RADIOFREQUENCY ABLATION ANALYSIS CASE STUDY 98

TABLE 32           CASE STUDY 2: THERMOCOOL CATHETER CASE STUDY              99

TABLE 33           THERMAL ABLATION TECHNOLOGY: KEY BRAND MAPPING              99

TABLE 34           NON-THERMAL ABLATION TECHNOLOGY: KEY BRAND MAPPING          100

TABLE 35           ABLATION TECHNOLOGY MARKET: INTENSITY OF CURRENT UNMET NEEDS 102

TABLE 36           ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)     106

TABLE 37           RADIOFREQUENCY ABLATION TECHNOLOGY MARKET, BY REGION,

2022–2029 (USD MILLION)          107

TABLE 38           LASER/LIGHT ABLATION TECHNOLOGY MARKET, BY REGION,

2022–2029 (USD MILLION)          108

TABLE 39          ULTRASOUND ABLATION TECHNOLOGY MARKET, BY REGION,

2022–2029 (USD MILLION)          109

TABLE 40           ELECTRICAL ABLATION TECHNOLOGY MARKET, BY REGION,

2022–2029 (USD MILLION)          110

TABLE 41           CRYOABLATION TECHNOLOGY MARKET, BY REGION, 2022–2029 (USD MILLION)     111

TABLE 42           MICROWAVE ABLATION TECHNOLOGY MARKET, BY REGION,

2022–2029 (USD MILLION)          112

TABLE 43           PULSED-FIELD ABLATION TECHNOLOGY MARKET, BY REGION,

2022–2029 (USD MILLION)          113

TABLE 44           HYDROTHERMAL/HYDROMECHANICAL ABLATION TECHNOLOGY MARKET,

BY REGION, 2022–2029 (USD MILLION)  113

TABLE 45           ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 115

TABLE 46           ABLATION TECHNOLOGY SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)     115

TABLE 47           RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          116

TABLE 48           RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY REGION,

2022–2029 (USD MILLION)          116

TABLE 49           TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATION SYSTEMS MARKET,

BY REGION, 2022–2029 (USD MILLION)  117

TABLE 50           FLUID-COOLED RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)            118

TABLE 51           ROBOTIC CATHETER MANIPULATION SYSTEMS MARKET, BY REGION,

2022–2029 (USD MILLION)          119

TABLE 52           LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)     119

TABLE 53           LASER/LIGHT ABLATION SYSTEMS MARKET, BY REGION,

2022–2029 (USD MILLION)          120

TABLE 54           EXCIMER LASER ABLATION SYSTEMS MARKET, BY REGION,

2022–2029 (USD MILLION)          120

TABLE 55           COLD LASER ABLATION SYSTEMS MARKET, BY REGION,

2022–2029 (USD MILLION)          121

TABLE 56           ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)     122

TABLE 57           ULTRASOUND ABLATION SYSTEMS MARKET, BY REGION,

2022–2029 (USD MILLION)        122

TABLE 58           ULTRASONIC SURGICAL ABLATION SYSTEMS MARKET, BY REGION,

2022–2029 (USD MILLION)          123

TABLE 59           HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION SYSTEMS MARKET,

BY REGION, 2022–2029 (USD MILLION)  124

TABLE 60           EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY SYSTEMS MARKET,

BY REGION, 2022–2029 (USD MILLION)  124

TABLE 61           MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND ABLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)   125

TABLE 62           ELECTRICAL ABLATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)     126

TABLE 63           ELECTRICAL ABLATION SYSTEMS MARKET, BY REGION,

2022–2029 (USD MILLION)          126

TABLE 64           ARGON PLASMA/BEAM COAGULATION SYSTEMS MARKET, BY REGION,

2022–2029 (USD MILLION)          127

TABLE 65           IRREVERSIBLE ELECTROPORATION ABLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)            128

TABLE 66           CRYOABLATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 128

TABLE 67           MICROWAVE ABLATION SYSTEMS MARKET, BY REGION,

2022–2029 (USD MILLION)          129

TABLE 68           HYDROTHERMAL/HYDROMECHANICAL ABLATION SYSTEMS MARKET,

BY REGION, 2022–2029 (USD MILLION)  130

TABLE 69           ABLATION TECHNOLOGY CONSUMABLES MARKET, BY REGION,

2022–2029 (USD MILLION)          131

TABLE 70           ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     133

TABLE 71           ABLATION TECHNOLOGY MARKET FOR CARDIOVASCULAR DISEASE TREATMENT,

BY REGION, 2022–2029 (USD MILLION)  134

TABLE 72          ABLATION TECHNOLOGY MARKET FOR CANCER TREATMENT, BY REGION,

2022–2029 (USD MILLION)          136

TABLE 73           ABLATION TECHNOLOGY MARKET FOR ORTHOPEDIC TREATMENT, BY REGION, 2022–2029 (USD MILLION)     137

TABLE 74           ABLATION TECHNOLOGY MARKET FOR COSMETIC/AESTHETIC SURGERY,

BY REGION, 2022–2029 (USD MILLION)  138

TABLE 75           ABLATION TECHNOLOGY MARKET FOR UROLOGICAL TREATMENT, BY REGION, 2022–2029 (USD MILLION)     139

TABLE 76           ABLATION TECHNOLOGY MARKET FOR GYNECOLOGICAL TREATMENT, BY REGION, 2022–2029 (USD MILLION)     140

TABLE 77           ABLATION TECHNOLOGY MARKET FOR PAIN MANAGEMENT, BY REGION,

2022–2029 (USD MILLION)          141

TABLE 78           ABLATION TECHNOLOGY MARKET FOR OPHTHALMOLOGICAL TREATMENT,

BY REGION, 2022–2029 (USD MILLION)  142

TABLE 79           ABLATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY REGION,

2022–2029 (USD MILLION)          142

TABLE 80           ABLATION TECHNOLOGY MARKET, BY END USER, 2022–2029 (USD MILLION) 144

TABLE 81           ABLATION TECHNOLOGY MARKET FOR HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS, BY REGION, 2022–2029 (USD MILLION)          145

TABLE 82           ABLATION TECHNOLOGY MARKET FOR AMBULATORY SURGERY CENTERS,

BY REGION, 2022–2029 (USD MILLION)  146

TABLE 83           ABLATION TECHNOLOGY MARKET FOR MEDICAL SPAS AND AESTHETIC & DERMATOLOGY CLINICS, BY REGION, 2022–2029 (USD MILLION)              147

TABLE 84           ABLATION TECHNOLOGY MARKET FOR OTHER END USERS, BY REGION,

2022–2029 (USD MILLION)          147

TABLE 85           ABLATION TECHNOLOGY MARKET, BY REGION, 2022–2029 (USD MILLION) 149

TABLE 86           NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          150

TABLE 87           NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          151

TABLE 88           NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          151

TABLE 89           NORTH AMERICA: ABLATION TECHNOLOGY SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          152

TABLE 90           NORTH AMERICA: RADIOFREQUENCY ABLATION SYSTEMS MARKET,

BY TYPE, 2022–2029 (USD MILLION)       152

TABLE 91          NORTH AMERICA: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          153

TABLE 92           NORTH AMERICA: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          153

TABLE 93           NORTH AMERICA: ELECTRICAL ABLATION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          154

TABLE 94           NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          154

TABLE 95           NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY END USER,

2022–2029 (USD MILLION)          155

TABLE 96           NORTH AMERICA: KEY MACROINDICATORS     156

TABLE 97           US: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          157

TABLE 98           CANADA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          158

TABLE 99           EUROPE: ABLATION TECHNOLOGY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          159

TABLE 100         EUROPE: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          159

TABLE 101         EUROPE: ABLATION TECHNOLOGY MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          160

TABLE 102         EUROPE: ABLATION TECHNOLOGY SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          160

TABLE 103         EUROPE: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)        161

TABLE 104         EUROPE: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          161

TABLE 105         EUROPE: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          162

TABLE 106         EUROPE: ELECTRICAL ABLATION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)        162

TABLE 107         EUROPE: ABLATION TECHNOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          163

TABLE 108         EUROPE: ABLATION TECHNOLOGY MARKET, BY END USER,

2022–2029 (USD MILLION)          163

TABLE 109         EUROPE: KEY MACROINDICATORS        164

TABLE 110         GERMANY: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          165

TABLE 111         FRANCE: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          166

TABLE 112         UK: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          167

TABLE 113         ITALY: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          168

TABLE 114         SPAIN: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          169

TABLE 115         REST OF EUROPE: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          170

TABLE 116         ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          172

TABLE 117         ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          172

TABLE 118         ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          173

TABLE 119         ASIA PACIFIC: ABLATION TECHNOLOGY SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          173

TABLE 120         ASIA PACIFIC: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          174

TABLE 121         ASIA PACIFIC: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          174

TABLE 122         ASIA PACIFIC: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          175

TABLE 123         ASIA PACIFIC: ELECTRICAL ABLATION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          175

TABLE 124         ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          176

TABLE 125         ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY END USER,

2022–2029 (USD MILLION)          176

TABLE 126         ASIA PACIFIC: KEY MACROINDICATORS             178

TABLE 127         JAPAN: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          179

TABLE 128         CHINA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          180

TABLE 129         INDIA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          181

TABLE 130         AUSTRALIA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          182

TABLE 131         SOUTH KOREA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          183

TABLE 132         REST OF ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          184

TABLE 133         LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          184

TABLE 134         LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          185

TABLE 135         LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          185

TABLE 136        LATIN AMERICA: ABLATION TECHNOLOGY SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          186

TABLE 137         LATIN AMERICA: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          186

TABLE 138         LATIN AMERICA: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          187

TABLE 139         LATIN AMERICA: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          187

TABLE 140         LATIN AMERICA: ELECTRICAL ABLATION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          188

TABLE 141         LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          188

TABLE 142         LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY END USER,

2022–2029 (USD MILLION)          189

TABLE 143         LATIN AMERICA: KEY MACROINDICATORS        190

TABLE 144        BRAZIL: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          191

TABLE 145         MEXICO: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          192

TABLE 146         REST OF LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)    193

TABLE 147         MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)    194

TABLE 148         MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          194

TABLE 149         MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY SYSTEMS MARKET,

BY TYPE, 2022–2029 (USD MILLION)       195

TABLE 150         MIDDLE EAST & AFRICA: RADIOFREQUENCY ABLATION SYSTEMS MARKET,

BY TYPE, 2022–2029 (USD MILLION)       195

TABLE 151         MIDDLE EAST & AFRICA: LASER/LIGHT ABLATION SYSTEMS MARKET,

BY TYPE, 2022–2029 (USD MILLION)       196

TABLE 152         MIDDLE EAST & AFRICA: ULTRASOUND ABLATION SYSTEMS MARKET,

BY TYPE, 2022–2029 (USD MILLION)       196

TABLE 153         MIDDLE EAST & AFRICA: ELECTRICAL ABLATION SYSTEMS MARKET,

BY TYPE, 2022–2029 (USD MILLION)       197

TABLE 154         MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     197

TABLE 155         MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY END USER,

2022–2029 (USD MILLION)          198

TABLE 156         MIDDLE EAST & AFRICA: KEY MACROINDICATORS        199

TABLE 157         OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN ABLATION TECHNOLOGY MARKET      200

TABLE 158         ABLATION TECHNOLOGY MARKET: DEGREE OF COMPETITION 204

TABLE 159         ABLATION TECHNOLOGY MARKET: TECHNOLOGY FOOTPRINT      208

TABLE 160         ABLATION TECHNOLOGY MARKET: PRODUCT FOOTPRINT              209

TABLE 161         ABLATION TECHNOLOGY MARKET: APPLICATION FOOTPRINT      210

TABLE 162         ABLATION TECHNOLOGY MARKET: END-USER FOOTPRINT              211

TABLE 163         ABLATION TECHNOLOGY MARKET: REGION FOOTPRINT              212

TABLE 164         ABLATION TECHNOLOGY MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS            215

TABLE 165         ABLATION TECHNOLOGY MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS        216

TABLE 166         ABLATION TECHNOLOGY MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–JULY 2024       219

TABLE 167         ABLATION TECHNOLOGY MARKET: DEALS, JANUARY 2021–JULY 2024          220

TABLE 168         ABLATION TECHNOLOGY MARKET: EXPANSIONS, JANUARY 2021–JULY 2024 221

TABLE 169         JOHNSON & JOHNSON: COMPANY OVERVIEW  222

TABLE 170         JOHNSON & JOHNSON: PRODUCTS OFFERED   223

TABLE 171         JOHNSON & JOHNSON: PRODUCT APPROVALS, JANUARY 2021−JULY 2024             224

TABLE 172         JOHNSON & JOHNSON: DEALS, JANUARY 2021−JULY 2024              225

TABLE 173         MEDTRONIC: COMPANY OVERVIEW     226

TABLE 174         MEDTRONIC: PRODUCTS OFFERED      228

TABLE 175         MEDTRONIC: PRODUCT APPROVALS, JANUARY 2021−JULY 2024      230

TABLE 176         BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW              232

TABLE 177         BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED              233

TABLE 178         BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS,

JANUARY 2021−JULY 2024          235

TABLE 179         BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021−JULY 2024             235

TABLE 180         ABBOTT: COMPANY OVERVIEW             237

TABLE 181         ABBOTT: PRODUCTS OFFERED 238

TABLE 182         ABBOTT: PRODUCT APPROVALS, JANUARY 2021−JULY 2024              239

TABLE 183         ABBOTT: DEALS, JANUARY 2021−JULY 2024       239

TABLE 184         ATRICURE, INC.: COMPANY OVERVIEW 240

TABLE 185         ATRICURE, INC.: PRODUCTS OFFERED 241

TABLE 186         ATRICURE, INC.: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021−JULY 2024          242

TABLE 187         ANGIODYNAMICS: COMPANY OVERVIEW          243

TABLE 188         ANGIODYNAMICS: PRODUCTS OFFERED           245

TABLE 189         ANGIODYNAMICS: DEALS, JANUARY 2021−JULY 2024    246

TABLE 190         CONMED CORPORATION: COMPANY OVERVIEW           247

TABLE 191         CONMED CORPORATION: PRODUCTS OFFERED            248

TABLE 192         OLYMPUS CORPORATION: COMPANY OVERVIEW          249

TABLE 193         OLYMPUS CORPORATION: PRODUCTS OFFERED           250

TABLE 194         OLYMPUS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021−JULY 2024             251

TABLE 195         OLYMPUS CORPORATION: DEALS, JANUARY 2021−JULY 2024              252

TABLE 196         VARIAN MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW              253

TABLE 197         VARIAN MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED              254

TABLE 198         VARIAN MEDICAL SYSTEMS, INC.: PRODUCT LAUNCHES,

JANUARY 2021−JULY 2024          255

TABLE 199         VARIAN MEDICAL SYSTEMS, INC.: DEALS, JANUARY 2021−JULY 2024      255

TABLE 200         SMITH+NEPHEW: COMPANY OVERVIEW            257

TABLE 201         SMITH+NEPHEW: PRODUCTS OFFERED             259

TABLE 202         SMITH+NEPHEW: EXPANSIONS, JANUARY 2021−JULY 2024              260

TABLE 203         STRYKER: COMPANY OVERVIEW            261

TABLE 204         STRYKER: PRODUCTS OFFERED             263

TABLE 205         STRYKER: PRODUCT APPROVALS, JANUARY 2021−JULY 2024              263

TABLE 206         STRYKER: EXPANSIONS, JANUARY 2021−JULY 2024        264

TABLE 207         CYNOSURE LUTRONIC: COMPANY OVERVIEW  265

TABLE 208         CYNOSURE LUTRONIC: PRODUCTS OFFERED   265

TABLE 209         CYNOSURE LUTRONIC: DEALS, JANUARY 2021−JULY 2024              266

TABLE 210         BIOVENTUS: COMPANY OVERVIEW       267

TABLE 211         BIOVENTUS: PRODUCTS OFFERED        268

TABLE 212         BIOVENTUS: DEALS, JANUARY 2021−JULY 2024 269

TABLE 213         MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW         270

TABLE 214         MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED          271

TABLE 215         CANYON MEDICAL INC.: COMPANY OVERVIEW 272

TABLE 216         CANYON MEDICAL INC.: PRODUCTS OFFERED 272

TABLE 217         ARTHREX, INC.: COMPANY OVERVIEW 273

TABLE 218         ICECURE MEDICAL: COMPANY OVERVIEW        274

TABLE 219         MINIMAX MEDICAL HOLDING GROUP: COMPANY OVERVIEW              275

TABLE 220         CARDIOFOCUS: COMPANY OVERVIEW 276

TABLE 221         EDAP TMS: COMPANY OVERVIEW         277

TABLE 222         MERMAID MEDICAL: COMPANY OVERVIEW      278

TABLE 223         MONTERIS: COMPANY OVERVIEW         278

TABLE 224         SONABLATE CORP.: COMPANY OVERVIEW        279

TABLE 225         ECO MEDICAL: COMPANY OVERVIEW  280

TABLE 226         SURGNOVA: COMPANY OVERVIEW       281

LIST OF FIGURES

FIGURE 1           ABLATION TECHNOLOGY MARKET: SEGMENTS CONSIDERED              30

FIGURE 2           ABLATION TECHNOLOGY MARKET: YEARS CONSIDERED              31

FIGURE 3           ABLATION TECHNOLOGY MARKET: RESEARCH DESIGN              33

FIGURE 4           ABLATION TECHNOLOGY MARKET: KEY PRIMARY SOURCES              35

FIGURE 5           ABLATION TECHNOLOGY MARKET: KEY PRIMARY INSIGHTS              36

FIGURE 6           BREAKDOWN OF PRIMARY INTERVIEWS:

SUPPLY- AND DEMAND-SIDE PARTICIPANTS    36

FIGURE 7           BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,

DESIGNATION, AND REGION    37

FIGURE 8           RESEARCH METHODOLOGY: HYPOTHESIS BUILDING  38

FIGURE 9           ABLATION TECHNOLOGY MARKET: COMPANY REVENUE ESTIMATION APPROACH           39

FIGURE 10         ABLATION TECHNOLOGY MARKET: CUSTOMER-BASED MARKET ESTIMATION  40

FIGURE 11         CAGR PROJECTION: SUPPLY-SIDE ANALYSIS     41

FIGURE 12         DATA TRIANGULATION METHODOLOGY         42

FIGURE 13         ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY,

2024 VS. 2029 (USD MILLION)     45

FIGURE 14         ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)     46

FIGURE 15         ABLATION TECHNOLOGY MARKET, BY APPLICATION,

2024 VS. 2029 (USD MILLION)     46

FIGURE 16         ABLATION TECHNOLOGY MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)     47

FIGURE 17         ABLATION TECHNOLOGY MARKET: REGIONAL SNAPSHOT              48

FIGURE 18         INCREASING DEMAND FOR MINIMALLY INVASIVE PROCEDURES TO DRIVE MARKET          49

FIGURE 19         PULSED-FIELD ABLATION TO REGISTER HIGHEST CAGR IN NORTH AMERICAN MARKET DURING FORECAST PERIOD          50

FIGURE 20         AMBULATORY SURGERY CENTERS TO REGISTER HIGHEST GROWTH

RATE DURING FORECAST PERIOD         51

FIGURE 21         CARDIOVASCULAR DISEASE TREATMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2029          52

FIGURE 22         INDIA TO WITNESS HIGHEST CAGR DURING STUDY PERIOD              53

FIGURE 23         ABLATION TECHNOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    54

FIGURE 24         ABLATION TECHNOLOGY MARKET: VALUE CHAIN ANALYSIS              62

FIGURE 25         ABLATION TECHNOLOGY MARKET: SUPPLY CHAIN ANALYSIS              64

FIGURE 26         ABLATION TECHNOLOGY MARKET: ECOSYSTEM ANALYSIS              65

FIGURE 27         PREMARKET NOTIFICATION: 510(K) APPROVAL FOR MEDICAL DEVICES            68

FIGURE 28         CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES            70

FIGURE 29         EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES              72

FIGURE 30         FUNDING AND NUMBER OF DEALS IN ABLATION TECHNOLOGY MARKET, 2018−2022 (USD MILLION)     83

FIGURE 31         NUMBER OF INVESTOR DEALS IN ABLATION TECHNOLOGY MARKET,

BY KEY PLAYER, 2018–2022 (UNIT)          83

FIGURE 32         VALUE OF INVESTOR DEALS IN ABLATION TECHNOLOGY MARKET,

BY KEY PLAYER, 2018–2022 (USD MILLION)       84

FIGURE 33         AVERAGE SELLING PRICE TREND OF ABLATION SYSTEMS, BY TECHNOLOGY (2023)   85

FIGURE 34         AVERAGE SELLING PRICE TREND OF ABLATION SYSTEMS, BY REGION (2023) 85

FIGURE 35         TOP PATENT OWNERS/APPLICANTS IN

ABLATION TECHNOLOGY MARKET (2013–2023) 89

FIGURE 36         ABLATION TECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS          91

FIGURE 37         INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ABLATION TECHNOLOGY PRODUCTS  93

FIGURE 38         KEY BUYING CRITERIA 95

FIGURE 39         KEY BUYING CRITERIA FOR END USERS              96

FIGURE 40         ABLATION TECHNOLOGY MARKET: TRENDS/DISRUPTIONS IMPACTING

CUSTOMER BUSINESS   101

FIGURE 41         MARKET POTENTIAL OF AI/GENERATIVE AI ON ABLATION TECHNOLOGIES            103

FIGURE 42         NORTH AMERICA: ABLATION TECHNOLOGY MARKET SNAPSHOT        150

FIGURE 43         ASIA PACIFIC: ABLATION TECHNOLOGY MARKET SNAPSHOT              171

FIGURE 44         REVENUE ANALYSIS OF KEY PLAYERS IN ABLATION TECHNOLOGY MARKET (2019−2023)    203

FIGURE 45         MARKET SHARE ANALYSIS OF KEY PLAYERS IN ABLATION

TECHNOLOGY MARKET (2023) 204

FIGURE 46         ABLATION TECHNOLOGY MARKET: COMPANY EVALUATION

MATRIX (KEY PLAYERS), 2023    206

FIGURE 47         ABLATION TECHNOLOGY MARKET: COMPANY FOOTPRINT              207

FIGURE 48         ABLATION TECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023           214

FIGURE 49         EV/EBITDA OF KEY VENDORS   217

FIGURE 50         YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK

BETA OF KEY VENDORS             217

FIGURE 51         ABLATION TECHNOLOGY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS          218

FIGURE 52         JOHNSON & JOHNSON: COMPANY SNAPSHOT (2023)    223

FIGURE 53         MEDTRONIC: COMPANY SNAPSHOT (2023)       227

FIGURE 54         BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)   233

FIGURE 55         ABBOTT: COMPANY SNAPSHOT (2023) 238

FIGURE 56         ATRICURE, INC.: COMPANY SNAPSHOT (2023)  241

FIGURE 57         ANGIODYNAMICS: COMPANY SNAPSHOT (2023)            244

FIGURE 58         CONMED CORPORATION: COMPANY SNAPSHOT (2023)              248

FIGURE 59         OLYMPUS CORPORATION: COMPANY SNAPSHOT (2023)              250

FIGURE 60         VARIAN MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2023)              254

FIGURE 61         SMITH+NEPHEW: COMPANY SNAPSHOT (2023) 258

FIGURE 62         STRYKER: COMPANY SNAPSHOT (2023) 262

FIGURE 63         BIOVENTUS: COMPANY SNAPSHOT (2023)         268

FIGURE 64         MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2023)              271

MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 栄養補助食品用包装市場 – 2030年までの世界予測 2025-04-07
• 産業用ボイラー市場 – 2030年までの世界予測 2025-04-04
• オープンギア用潤滑油市場 – 2030年までの世界予測 2025-04-04
• 建設重機市場 – 2030年までの世界予測 2025-04-03
• 従来の創傷ケア市場 – 2030年までの世界予測 2025-04-02

MarketsandMarkets  出版レポート一覧